BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 12, 2010
 |  BC Week In Review  |  Company News  |  Deals

Drugs for Neglected Diseases initiative, TB Alliance deal

DNDi received a non-exclusive, worldwide, royalty-free license to develop the TB Alliance's compounds from the nitroimidazole class for use against neglected tropical diseases, including visceral leishmaniasis (VL), human...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >